We demonstrated that miR-125b was down-regulated in HCC tissues and cell lines and was able to inhibit the cell proliferation and cell cycle progression of HCC cells by targeting Mcl-1 and IL6R. Here, IL6R is linked to hepatocellular carcinoma.